Suppr超能文献

中药中的草药化学成分对阿尔茨海默病的治疗作用

Therapeutic Effects of Herbal Chemicals in Traditional Chinese Medicine on Alzheimer's Disease.

作者信息

Cheung T S, Song T H, Ng T B, Wu F H, Lao L X, Tang S C W, Ho J C M, Zhang K Y B, Sze S C W

机构信息

School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.

出版信息

Curr Med Chem. 2015;22(19):2392-403. doi: 10.2174/0929867322666150520095509.

Abstract

Alzheimer's disease (AD) is the most common type of dementia that leads to increasing death and mental disability among humans. Current therapy of AD mainly relies on the use of acetylcholinesterase inhibitors (AChEIs) or antagonists of N-methyl-D-aspartate receptors (NMDARs), which only relieve the symptoms of the disease but not halt its progression. Nevertheless, Traditional Chinese medicines (TCM) are highly prized as many bioactive components isolated from TCM are beneficial for treating AD. In this review, we summarize the latest information on TCM and the bioactive components according to their mechanistic role in alleviating AD. They act as modulators of α- and β-secretases, and inhibitors of betaamyloid (Aβ) aggregation. Some of them suppress Aβ-induced neuronal cytotoxicity and inflammation. Hence, this work has demonstrated the feasibility of applying TCM in AD therapy and the possibility of screening of constituents in TCM in the near future.

摘要

阿尔茨海默病(AD)是最常见的痴呆类型,导致人类死亡增加和智力残疾。目前AD的治疗主要依赖于使用乙酰胆碱酯酶抑制剂(AChEIs)或N-甲基-D-天冬氨酸受体(NMDARs)拮抗剂,这些药物只能缓解疾病症状,而不能阻止其进展。然而,中药备受推崇,因为从中药中分离出的许多生物活性成分对治疗AD有益。在本综述中,我们根据其在缓解AD中的作用机制,总结了关于中药及其生物活性成分的最新信息。它们可作为α-和β-分泌酶的调节剂以及β-淀粉样蛋白(Aβ)聚集的抑制剂。其中一些还可抑制Aβ诱导的神经元细胞毒性和炎症。因此,这项工作证明了将中药应用于AD治疗的可行性以及在不久的将来筛选中药成分的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验